The ongoing damage to Greek scientific research is not solely due to austerity measures (Nature 517, 127-128; 2015) . In my experience as a member of Greece's National Council for Research and Technology from 2010 to 2014, political manipulation and institutional weakness are also contributors.
To address the dire problem of underfunded research, in 2011 the council introduced an open, competitive grant scheme (called Aristeia, or excellence) based on the European Research Council model. It ran for two rounds, during which we had to battle against other governmental forces to maintain its European Union (EU) funding. The scheme now seems to have been abandoned.
The council developed a multiannual plan that year for research and development (R&D) to bring Greece closer to EU expenditure targets by 2020. This was stalled and diverted by government. We pressed for the creation of a high-level government committee to oversee R&D, and for a research agency similar to the US National Science Foundation. That plan was also lost, diluted by the research law you mention.
The council's experience reflects the wider problems of Greece's government: how it seeks and receives expert advice, the public status of this process and the near-impossibility of rational, stable long-term planning. The shallow and short-term strictures of the 'troika' -the three organizations that act for Greece's creditors -make matters worse. 438; 2015) . This could be difficult, given the wide variation in each state's willingness to participate and in their investment in research.
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Research excellence and competitiveness remain concentrated in just a few geographical areas, despite efforts by the EU to promote homogeneity. It is those regions that make the advances in research and technology, fuelling the imbalance (see K. Schwab (ed.) The Global Competitiveness Report 2013 -2014 World Economic Forum, 2013 .
The EU plan to align national research programmes could make matters worse. Closer cooperation between researchers and between states will help to secure research sponsorship and collaboration with scientists outside Europe. But these advantages are more likely to be enjoyed by highperforming countries, further widening the gap from the others. The proposed alignment will also have to struggle with extra bureaucracy and delays (M. Cuijpers et al. Res. Policy 40, 565-575; 2011 
